Cited by 166

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents

Cipriani, Raffaela, Villa, Pia, Chece, Giuseppina, Lauro, Clotilde, Paladini, Alessandra, Micotti, Edoardo, Perego, Carlo, De Simoni, Maria-Grazia, Fredholm, Bertil B., Eusebi, Fabrizio, Limatola, Cristina·2011·The Journal of Neuroscience

Abstract

The chemokine CX3CL1 and its receptor CX3CR1 are constitutively expressed in the nervous system. In this study, we used in vivo murine models of permanent middle cerebral artery occlusion (pMCAO) to investigate the protective potential of CX3CL1. We report that exogenous CX3CL1 reduced ischemia-induced cerebral infarct size, neurological deficits, and caspase-3 activation. CX3CL1-induced neuroprotective effects were long lasting, being observed up to 50 d after pMCAO in rats. The neuroprotective action of CX3CL1 in different models of brain injuries is mediated by its inhibitory activity on microglia and, in vitro , requires the activation of adenosine receptor 1 (A 1 R). We show that, in the presence of the A 1 R antagonist 1,3-dipropyl-8-cyclopentylxanthine and in A 1 R −/− mice, the neuroprotective effect of CX3CL1 on pMCAO was abolished, indicating the critical importance of the adenosine system in CX3CL1 protection also in vivo . In apparent contrast with the above reported data but in agreement with previous findings, cx3cl1 −/− and cx3cr1 GFP/GFP mice, respectively, deficient in CX3CL1 or CX3CR1, had less severe brain injury on pMCAO, and the administration of exogenous CX3CL1 increased brain damage in cx3cl1 −/− ischemic mice. We also report that CX3CL1 induced a different phagocytic activity in wild type and cx3cl1 −/− microglia in vitro during cotreatment with the medium conditioned by neurons damaged by oxygen-glucose deprivation. Together, these data suggest that acute administration of CX3CL1 reduces ischemic damage via an adenosine-dependent mechanism and that the absence of constitutive CX3CL1–CX3CR1 signaling changes the outcome of microglia-mediated effects during CX3CL1 administration to ischemic brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3611-11.2011

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 11 references

Research works printed but not linked: 38

  1. 10.1161/01.STR.23.9.1337 · DOI
  2. 10.1016/j.tins.2007.08.007 · DOI · Paper page
  3. 10.1161/STROKEAHA.108.531632 · DOI
  4. Chapman, 2000, Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage, J Neurosci, 20, 1
  5. 10.1128/MCB.21.9.3159-3165.2001 · DOI
  6. 10.1007/s11302-005-0649-1 · DOI
  7. 10.1038/jcbfm.2008.64 · DOI · Paper page
  8. 10.1016/S0166-2236(99)01401-0 · DOI · Paper page
  9. 10.1038/sj.cdd.4402132 · DOI
  10. 10.1073/pnas.95.18.10896 · DOI · Paper page
  11. 10.1038/sj.jcbfm.9600362 · DOI
  12. 10.1073/pnas.161292398 · DOI
  13. 10.1128/MCB.20.11.4106-4114.2000 · DOI · Paper page
  14. 10.1007/s00210-009-0477-x · DOI
  15. 10.1002/glia.20610 · DOI
  16. 10.1523/JNEUROSCI.5360-06.2007 · DOI · Paper page
  17. 10.1523/JNEUROSCI.5505-08.2009 · DOI
  18. 10.1038/npp.2010.26 · DOI
  19. 10.4049/jimmunol.180.11.7590 · DOI · Paper page
  20. 10.1016/j.jneuroim.2005.03.023 · DOI · Paper page
  21. 10.1016/S0006-8993(03)02867-1 · DOI
  22. 10.1038/sj.bmt.1701300 · DOI
  23. Namura, 1998, Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia, J Neurosci, 18, 3659, 10.1523/JNEUROSCI.18-10-03659.1998 · DOI
  24. 10.1371/journal.pone.0011746 · DOI
  25. 10.1074/jbc.M110.169839 · DOI
  26. 10.1111/j.1460-9568.2004.03564.x · DOI
  27. 10.1111/j.1471-4159.2006.03823.x · DOI
  28. 10.1016/0006-8993(95)01153-6 · DOI
  29. 10.1038/jcbfm.2008.121 · DOI
  30. 10.1124/jpet.106.105064 · DOI
  31. 10.1046/j.1460-9568.2002.02007.x · DOI
  32. Villa, 2007, The interleukin-8 (IL(/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats, Mol Med, 13, 125, 10.2119/2007-00008.Villa · DOI
  33. 10.1016/0014-2999(96)00101-X · DOI
  34. 10.1016/j.neulet.2005.02.019 · DOI
  35. 10.1097/01.WCB.0000122742.72175.1B · DOI
  36. 10.1073/pnas.95.26.15769 · DOI · Paper page
  37. 10.1016/j.brainres.2009.06.068 · DOI
  38. 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V · DOI

Cited by

Sorted by citations

See all 166

Metadata

Authors
Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M.-G., Fredholm, B. B., Eusebi, F., & Limatola, C.
Venue
The Journal of Neuroscience
Published
2011-11-09
Volume
31
Issue
45
Pages
16327-16335
ISSN
  • 0270-6474
  • 1529-2401
Cited by
166
References
11
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review